TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27333864)

Published in Sci Rep on June 23, 2016

Authors

Matthew Murphy1, Sujash S Chatterjee1,2, Sidharth Jain3, Manpreet Katari3, Ramanuj DasGupta1,4

Author Affiliations

1: New York University Langone Medical Center, Perlmutter Cancer Center, Department of Stem Cell Biology, 522 1st Ave., Smilow Research Building, Rm 1206 New York, NY, 10016, USA.
2: University of Houston, Department of Biochemistry and Biology, Science &Research Building 2, 3455 Cullen Blvd #342, Houston, TX 77004, USA.
3: New York University, Department of Biology, 1009 Silver Center, 100 Washington Square East, New York, NY, 10003, USA.
4: Genome Institute of Singapore, Cancer Therapeutics and Stratified Oncology, 60 Biopolis Street, #02-01, Genome, 138672, Singapore.

Articles cited by this

The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39

Fast gapped-read alignment with Bowtie 2. Nat Methods (2012) 83.79

Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53

Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (2014) 44.23

Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol (2013) 32.42

Lessons from hereditary colorectal cancer. Cell (1996) 25.73

Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25

Wnt signalling in stem cells and cancer. Nature (2005) 19.26

Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 15.98

Wnt signaling: a common theme in animal development. Genes Dev (1997) 12.94

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (1992) 10.12

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53

Ensembl 2015. Nucleic Acids Res (2014) 8.30

Software for computing and annotating genomic ranges. PLoS Comput Biol (2013) 8.20

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods (2015) 6.11

Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev (2008) 4.77

Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology (2005) 4.09

Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protoc (2013) 4.00

WNTs modulate cell fate and behavior during vertebrate development. Trends Genet (1997) 3.44

Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle (2009) 3.14

Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol (2008) 3.02

All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res (2001) 2.98

EphB receptor activity suppresses colorectal cancer progression. Nature (2005) 2.84

Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology (2012) 2.57

EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet (2007) 2.33

Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal. Stem Cells (2008) 2.20

A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci U S A (2008) 2.10

Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci U S A (2012) 1.93

An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci U S A (2011) 1.92

Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem (2006) 1.86

Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res (2010) 1.81

TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol (2012) 1.78

CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med (2008) 1.58

EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res (2006) 1.50

Wnt signaling regulates neuronal differentiation of cortical intermediate progenitors. J Neurosci (2011) 1.31

Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis (2009) 1.19

Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol (2012) 1.11

Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J (2014) 1.05

Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling. Cell Rep (2013) 1.03

Molecular functions of the TLE tetramerization domain in Wnt target gene repression. EMBO J (2014) 1.02

Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3. Cancer Res (2012) 0.96

A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Cell Cycle (2015) 0.87

The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia. Haematologica (2014) 0.85

The TCF C-clamp DNA binding domain expands the Wnt transcriptome via alternative target recognition. Nucleic Acids Res (2014) 0.84

Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells. Int J Clin Exp Med (2014) 0.81

Inhibition of β-catenin-TCF1 interaction delays differentiation of mouse embryonic stem cells. J Cell Biol (2015) 0.79

Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer. Proc Natl Acad Sci U S A (2014) 0.78